4.8 Article

N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2

期刊

AUTOPHAGY
卷 13, 期 10, 页码 1664-1678

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2017.1345411

关键词

ALIS; aggregates; CXCL10; DHA; IKBKB; IP10; IRF1; IRF3; KEAP1; LPS; MDM; NFE2L2; NFKB; OA; omega-3; p62; PUFA; STAT1; SQSTM1; TLR4; TNF

资金

  1. Norwegian Cancer Society
  2. Research Council of Norway through its Centres of Excellence funding program [223255/F50]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125838] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Inflammation is crucial in the defense against infections but must be tightly controlled to limit detrimental hyperactivation. Our diet influences inflammatory processes and omega-3 polyunsaturated fatty acids (n-3 PUFAs) have known anti-inflammatory effects. The balance of pro-and anti-inflammatory processes is coordinated by macrophages and macroautophagy/autophagy has recently emerged as a cellular process that dampens inflammation. Here we report that the n-3 PUFA docosahexaenoic acid (DHA) transiently induces cytosolic speckles of the autophagic receptor SQSTM1/p62 (sequestosome 1) (described as SQSTM1/p62-bodies) in macrophages. We suggest that the formation of SQSTM1/p62-bodies represents a fast mechanism of NFE2L2/Nrf2 (nuclear factor, erythroid 2 like 2) activation by recruitment of KEAP1 (kelch like ECH associated protein 1). Further, the autophagy receptor TAX1BP1 (Tax1 binding protein 1) and ubiquitinediting enzyme TNFAIP3/A20 (TNF alpha induced protein 3) could be identified in DHA-induced SQSTM1/p62bodies. Simultaneously, DHA strongly dampened the induction of pro-inflammatory genes including CXCL10 (C-X-C motif chemokine ligand 10) and we suggest that formation of SQSTM1/p62-bodies and activation of NFE2L2 leads to tolerance towards selective inflammatory stimuli. Finally, reduced CXCL10 levels were related to the improved clinical outcome in n-3 PUFA-supplemented heart-transplant patients and we propose CXCL10 as a robust marker for the clinical benefits mobilized by n-3 PUFA supplementation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据